Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

68Ga

  • First-in-Humans Study of <sup>68</sup>Ga-DOTA-Siglec-9, a PET Ligand Targeting Vascular Adhesion Protein 1
    Open Access
    First-in-Humans Study of 68Ga-DOTA-Siglec-9, a PET Ligand Targeting Vascular Adhesion Protein 1
    Riikka Viitanen, Olli Moisio, Petteri Lankinen, Xiang-Guo Li, Mikko Koivumäki, Sami Suilamo, Tuula Tolvanen, Kirsi Taimen, Markku Mali, Ia Kohonen, Ilpo Koskivirta, Vesa Oikonen, Helena Virtanen, Kristiina Santalahti, Anu Autio, Antti Saraste, Laura Pirilä, Pirjo Nuutila, Juhani Knuuti, Sirpa Jalkanen and Anne Roivainen
    Journal of Nuclear Medicine April 1, 2021, 62 (4) 577-583; DOI: https://doi.org/10.2967/jnumed.120.250696
  • You have access
    Radiation Dosimetry and Biodistribution of 68Ga-FAPI-46 PET Imaging in Cancer Patients
    Catherine Meyer, Magnus Dahlbom, Thomas Lindner, Sebastien Vauclin, Christine Mona, Roger Slavik, Johannes Czernin, Uwe Haberkorn and Jeremie Calais
    Journal of Nuclear Medicine August 1, 2020, 61 (8) 1171-1177; DOI: https://doi.org/10.2967/jnumed.119.236786
  • You have access
    Initial Clinical Results of a Novel Immuno-PET Theranostic Probe in Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer
    Caroline Rousseau, David M. Goldenberg, Mathilde Colombié, Jean-Charles Sébille, Philippe Meingan, Ludovic Ferrer, Pierre Baumgartner, Evelyne Cerato, Damien Masson, Mario Campone, Aurore Rauscher, Vincent Fleury, Catherine Labbe, Alain Faivre Chauvet, Jean-Sebastien Fresnel, Claire Toquet, Jacques Barbet, Robert M. Sharkey, Loic Campion and Françoise Kraeber-Bodéré
    Journal of Nuclear Medicine August 1, 2020, 61 (8) 1205-1211; DOI: https://doi.org/10.2967/jnumed.119.236000
  • You have access
    Improving Contrast and Detectability: Imaging with [55Co]Co-DOTATATE in Comparison with [64Cu]Cu-DOTATATE and [68Ga]Ga-DOTATATE
    Thomas L. Andersen, Christina Baun, Birgitte B. Olsen, Johan H. Dam and Helge Thisgaard
    Journal of Nuclear Medicine February 1, 2020, 61 (2) 228-233; DOI: https://doi.org/10.2967/jnumed.119.233015
  • You have access
    An Overview of PET Radiochemistry, Part 2: Radiometals
    Marie Brandt, Jens Cardinale, Margaret L. Aulsebrook, Gilles Gasser and Thomas L. Mindt
    Journal of Nuclear Medicine October 1, 2018, 59 (10) 1500-1506; DOI: https://doi.org/10.2967/jnumed.117.190801
  • You have access
    In Vivo Characterization of 4 68Ga-Labeled Multimeric RGD Peptides to Image αvβ3 Integrin Expression in 2 Human Tumor Xenograft Mouse Models
    Daphne Lobeek, Gerben M. Franssen, Michelle T. Ma, Hans-Jürgen Wester, Clemens Decristoforo, Wim J.G. Oyen, Otto C. Boerman, Samantha Y.A. Terry and Mark Rijpkema
    Journal of Nuclear Medicine August 1, 2018, 59 (8) 1296-1301; DOI: https://doi.org/10.2967/jnumed.117.206979
  • You have access
    Prospective Evaluation of 68Ga-RM2 PET/MRI in Patients with Biochemical Recurrence of Prostate Cancer and Negative Findings on Conventional Imaging
    Ryogo Minamimoto, Ida Sonni, Steven Hancock, Shreyas Vasanawala, Andreas Loening, Sanjiv S. Gambhir and Andrei Iagaru
    Journal of Nuclear Medicine May 1, 2018, 59 (5) 803-808; DOI: https://doi.org/10.2967/jnumed.117.197624
  • You have access
    Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of 68Ga-Tris(Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate Cancer
    Michael S. Hofman, Peter Eu, Price Jackson, Emily Hong, David Binns, Amir Iravani, Declan Murphy, Catherine Mitchell, Shankar Siva, Rodney J. Hicks, Jennifer D. Young, Philip J. Blower and Gregory E. Mullen
    Journal of Nuclear Medicine April 1, 2018, 59 (4) 625-631; DOI: https://doi.org/10.2967/jnumed.117.199554
  • You have access
    Accuracy of Dose Calibrators for 68Ga PET Imaging: Unexpected Findings in a Multicenter Clinical Pretrial Assessment
    Dale L. Bailey, Michael S. Hofman, Nicholas J. Forwood, Graeme J. O’Keefe, Andrew M. Scott, Winifred M. van Wyngaardt, Bonnie Howe, Olga Kovacev and Roslyn J. Francis; on behalf of ARTnet; and the ProPSMA Trial Investigators
    Journal of Nuclear Medicine April 1, 2018, 59 (4) 636-638; DOI: https://doi.org/10.2967/jnumed.117.202861
  • You have access
    68Ga-NOTA-Functionalized Ubiquicidin: Cytotoxicity, Biodistribution, Radiation Dosimetry, and First-in-Human PET/CT Imaging of Infections
    Thomas Ebenhan, Mike M. Sathekge, Thabo Lengana, Michel Koole, Olivier Gheysens, Thavendran Govender and Jan R. Zeevaart
    Journal of Nuclear Medicine February 1, 2018, 59 (2) 334-339; DOI: https://doi.org/10.2967/jnumed.117.200048

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire